The aim of this study was to investigate the longitudinal practice patterns of anemia treatment and the management of Hb and iron parameters, as well as the clinical outcomes in patients with NDD-CKD to provide novel and comprehensive epidemiologic information on anemia management in patients with NDD-CKD. This evidence concerns the gene GSTM1 and chronic kidney disease.